About IceCure
IceCure is a company based in Caesarea (Israel) founded in 2006. It operates as a HealthTech. IceCure has raised $4.5 million across 5 funding rounds from investors including EIP NY, Rosario Capital and Yaron Iluz. The company has 72 employees as of December 31, 2024. IceCure offers products and services including ProSense Cryoablation System. IceCure operates in a competitive market with competitors including Vessi Medical, Galil Medical, Sanarus, CAPS Medical and Hrain Biotechnology, among others.
- Headquarter Caesarea, Israel
- Employees 72 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Icecure Medical Ltd.
-
Annual Revenue
$3.29 M1.92as on Dec 31, 2024
-
Net Profit
$-15.32 M-4.55as on Dec 31, 2024
-
EBITDA
$-15.36 M-0.73as on Dec 31, 2024
-
Total Equity Funding
$4.5 M (USD)
in 5 rounds
-
Latest Funding Round
$7 M (USD), Post-IPO
Aug 10, 2020
-
Investors
EIP NY
& 8 more
-
Employee Count
72
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of IceCure
IceCure is a publicly listed company on the NASDAQ with ticker symbol ICCM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of IceCure
IceCure offers a comprehensive portfolio of products and services, including ProSense Cryoablation System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A system for minimally invasive tumor destruction used.
Unlock access to complete
Unlock access to complete
Funding Insights of IceCure
IceCure has successfully raised a total of $4.5M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $7.0M
-
First Round
First Round
(14 Apr 2008)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Post-IPO - IceCure | Valuation |
investors |
|
| Feb, 2015 | Amount | Post-IPO - IceCure | Valuation |
investors |
|
| Nov, 2013 | Amount | Post-IPO - IceCure | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IceCure
IceCure has secured backing from 9 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include EIP NY, Rosario Capital and Yaron Iluz. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward Israeli technology startups by Docor.
|
Founded Year | Domain | Location | |
|
VC firm investing in seed & early stage companies in Israel & the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IceCure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IceCure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Icecure Comparisons
Competitors of IceCure
IceCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vessi Medical, Galil Medical, Sanarus, CAPS Medical and Hrain Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of method for treating bladder cancer
|
|
| domain | founded_year | HQ Location |
A platform offering an online slot game for entertainment.
|
|
| domain | founded_year | HQ Location |
Breast cryoablation therapy for tumors is provided by Sanarus.
|
|
| domain | founded_year | HQ Location |
Cold atmospheric plasma technology is developed for tumor treatment.
|
|
| domain | founded_year | HQ Location |
Develops innovative technologies for tumor immunotherapy solutions.
|
|
| domain | founded_year | HQ Location |
Cold plasma delivery system for breast cancer treatment is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Icecure
Frequently Asked Questions about IceCure
When was IceCure founded?
IceCure was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Where is IceCure located?
IceCure is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
Who is the current CEO of IceCure?
Eyal Shamir is the current CEO of IceCure.
Is IceCure a funded company?
IceCure is a funded company, having raised a total of $4.5M across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $4M, raised on Apr 14, 2008.
How many employees does IceCure have?
As of Dec 31, 2024, the latest employee count at IceCure is 72.
What is the annual revenue of IceCure?
Annual revenue of IceCure is $3.29M as on Dec 31, 2024.
What does IceCure do?
IceCure Medical is engaged in developing and providing cryoablation systems for the treatment of benign and cancerous tumors. The ProSense Cryoablation System, powered by liquid nitrogen, is used to destroy tumors through freezing, offering a minimally invasive alternative to traditional surgery. Applications include breast tumors, kidney cancer, lung cancer, and palliative care. The company operates in the healthcare sector, specifically in interventional oncology and womens health, aiming to enhance patient and provider choice with convenient, office-based procedures. Solutions are supported by clinical studies like the ICE3 trial, demonstrating promising results in breast cancer treatment.
Who are the top competitors of IceCure?
IceCure's top competitors include Galil Medical, Vessi Medical and CAPS Medical.
What products or services does IceCure offer?
IceCure offers ProSense Cryoablation System.
Is IceCure publicly traded?
Yes, IceCure is publicly traded on NASDAQ under the ticker symbol ICCM.
Who are IceCure's investors?
IceCure has 9 investors. Key investors include EIP NY, Rosario Capital, Yaron Iluz, Naor El-Hai, and Docor.
What is IceCure's ticker symbol?
The ticker symbol of IceCure is ICCM on NASDAQ.